Option for Commercial License. 4.1 Carnegie Mellon hereby grants to Licensee the option (“Option”) to negotiate an exclusive license from Carnegie Mellon to manufacture, use, sell, lease or otherwise dispose of products and/or services based on, in whole or in part, the technology and intellectual property comprised in the Carnegie Mellon Materials and to practice under the Patent for exosome and cellular therapeutic applications.
Option for Commercial License to Subject Inventions NRL gives XYZ the option of acquiring an Exclusive or Nonexclusive Commercial License for the field of widget applications in the Government’s rights in any Subject Invention Made in whole or in part by a NRL employee. The license shall be for reasonable consideration. In order to exercise this option, XYZ must notify NRL in writing within one hundred and eighty (180) days of the filing of a Patent Application. Unless another time period is mutually agreed upon between the Collaborators, XYZ must execute an Exclusive or Nonexclusive Commercial License to the Subject Invention within one hundred and eighty (180) days of election to exercise the option, or the Invention shall be made available for licensing by the public in accordance with 37 CFR Part 404. Any Exclusive License granted by the Government in a Subject Invention is subject to the statutorily required reservation by the Government of a nonexclusive, irrevocable, paid-up license to practice the Subject Invention or have that Subject Invention practiced throughout the world by or on behalf of the Government (15 USC 3710a).
Option for Commercial License. In the event that COMPANY wishes to obtain a commercial license to the Research Results and/or any of Foundation’s IP rights related to the PROJECT, it will notify FOUNDATION in writing. Upon receiving such notification, FOUNDATION will grant to COMPANY a ninety (90) day option period ("Option Period"), beginning of the date of the notification, to negotiate for a royalty-bearing commercial license, the terms of which must be mutually agreeable to the parties. The Option Period may be set for a period of other than 90 days upon mutual written agreement of the parties.
Option for Commercial License. In the event that COMPANY notifies FOUNDATION that it wishes to obtain a commercial license as set forth in section 9(b)(8), FOUNDATION will negotiate the terms of such license in good faith with COMPANY during the Option Period.
Option for Commercial License. In the event that SPONSOR wishes to obtain a commercial license to the Research Results and/or any of FOUNDATION’s IP rights related to the Project, it will notify FOUNDATION in writing. Upon receiving such notification, FOUNDATION will grant to SPONSOR a ninety (90) day option period ("Option Period"), beginning of the date of the notification, to negotiate for a royalty-bearing commercial license, the terms of which must be mutually agreeable to the parties. The Option Period may be set for a period of other than 90 days upon mutual written agreement of the Parties.
Option for Commercial License. In the event that SPONSOR notifies FOUNDATION that it wishes to obtain a commercial license as set forth in section 9(b)(8), FOUNDATION will negotiate the terms of such license in good faith with SPONSOR during the Option Period.
Option for Commercial License. Subject to the terms of this Collaboration and Collaborator’s compliance herewith, CMC ICOS grants to Collaborator and Collaborator accepts an option, only during the Option Period, to acquire subject to the terms of this Collaboration and Collaborator’s compliance herewith, a [***] license, under the Patent Rights and Technical [ ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Information to make, have made, use, sell, offer for sale and import Products made with the Materials for human therapeutics or diagnostics (“Commercial License”). Unless Collaborator shall have obtained [***] a Commercial License on a particular Product as prescribed in Section 2 and 3, Collaborator agrees not to: (a) make or have made such Product other than as provided for in Section 2.1; or (b) sell, have sold, offer for sale, have offered for sale, transfer, have transferred, import or have imported such Product.
Option for Commercial License. With respect to any Research Product(s) arising from GI's use of the CAT Library Technology, GI retains an option to exclusively license (with right of sublicense) from CAT all of CAT's rights and interests (owned by or licensable by CAT) in and to such intellectual property relating to CAT Library Technology reasonably necessary for GI to develop, make, have made, use, sell, offer to sell, or import such Research Products ("Library Option Rights") provided however, GI' right to exercise such ---------------- an option is subject to [***].
Option for Commercial License
